article thumbnail

TO BE CONTINUED (!?): DEA Announces It is Issuing a “Temporary Rule” to Address Telemedicine Flexibilities After the End of the COVID-19 Pandemic Emergency

FDA Law Blog

Palmer — On May 3, 2023, DEA’s Administrator Anne Milgram issued a very brief and lightly publicized statement announcing that DEA intends to issue a “temporary rule” extending telemedicine flexibilities that existed during the COVID-19 Emergency Declaration, which Declaration is set to expire on May 11, 2023.

article thumbnail

Prognosis Superspecial: A Podcast with Kara Bischoff, James Deardorff, and Elizabeth Lilley

GeriPal

Eric 10:03 So you’re worried that maybe if you’re doing telemedicine, you wouldn’t be able to accurately engage functional status. God, it must have been like 2015, 2016. I don’t know how our patients manage that. Kara 10:08 Yep. Eric 10:09 So you’re reassured on that concern there. Kara 10:12 Yep.

Family 106
article thumbnail

Trump Whacks Agency That Makes the Nation’s Health Care Safer

Physicians News Digest

AHRQ research and guidelines played a key role in lowering the incidence of hospital-acquired infections — such as deadly blood infections caused by contaminated IV lines, which fell 28% from 2015 to 2023, according to the Centers for Disease Control and Prevention. million, he said.